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Figure 1: Computed tomography of thorax showing tumour
eroding rib (arrows)
Learn to see in another’s calamity the ills which you
should avoid.
Publilius Syrius, Sententiae
(c. 100 BC)
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Abstract
A 50 year old man presented with peripheral oedema,
abdominal distension and a pulmonary opacity on CXR.  He
subsequently perforated his sigmoid colon as a complication of
diverticulitis with pericolic abscess.  After colectomy his post-
operative period was marked by severe hypokalaemia, metabolic
alkalosis, hyperglycaemia and recurrent chest infections.
Paraneoplastic Cushing’s syndrome was diagnosed after finding
elevated serum cortisol and ACTH levels.  CT-guided biopsy of
the lung lesion revealed small-cell carcinoma.  Bone scan
disclosed collapse of numerous thoracic vertebrae possibly due
to osteoporosis or oncogenic osteomalacia.  Treatment with
steroid-synthesis blockers was commenced but the patient died
before tumour-directed therapy could be started.  Ectopic ACTH
syndrome and oncogenic osteomalacia are discussed.
Case Report
A 50 year old drydocks worker was referred to St. Luke’s
Hospital with pitting lower limb oedema.  His main complaint
was a fifteen day history of ankle swelling and abdominal
distension for which his family doctor had initially prescribed
an amiloride hydrochloride 5mg -  hydrochlorothiazide 50mg
combination (Moduretic®). This medication had been
discontinued four days prior to his first visit.
The medical history was unremarkable but for a
spontaneous left pneumothorax at 35 years of age which was
managed conservatively.  The patient had a long history of
cigarette smoking, having smoked around 20 cigarettes per
day since the age of 16 years.
On examination, he looked well, was eupnoeic at rest and
afebrile.  There was no jaundice, pallor, finger clubbing or
palpable lymph node enlargement.  Pulse rate was regular at
80 beats per minute and blood pressure was 130/80 mmHg.
Heart sounds were normal and the jugular venous pressure
was not elevated.  Chest auscultation was unremarkable.  The
abdomen was slightly distended: there was shifting dullness,
5 centimetre smooth hepatomegaly and a palpable tip of
spleen.  Digital rectal examination revealed normal stool and
there were no mucosal lesions or prostatic nodules.  He was
also noted to have hyperpigmented skin however his wife
maintained that she had always known him to have skin of
this tinge.
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Table 3: Further investigations
24 hour urinary K+ (mmol/day) 104 ( 5-250 )
Serum aldosterone ( pg/mL) 96 ( 12-150 )
Plasma renin activity (ng/mL/h) 3.68 ( 0.98-4.18 )
Serum cortisol 9am (nmol/L) >1380 ( 138-690 )
24 hr urinary cortisol (nmol/L/day) >1536 ( 55-276 )
ACTH (pg/mL) 349 ( <46 )
Table 2: Pre-op investigations
Haemoglobin (gm/dL) 16.2
White-cell count (per mm3) 14 800
Platelets (per mm3) 228 000
Urea (mmol/L) 7.3
Glucose fasting (mmol/L) 6.4
Sodium (mmol/L) 143
Potassium (mmol/L) 2.5
Arterial pH 7.504
HCO3- (mmol/L) 36.9
Table 1: Initial investigations
Haemoglobin (gm/dL) 14.3
White-cell count (per mm3) 12 340
Neutrophils (%) 80.3
Platelets (per mm3) 223 000
Erythrocyte sedimentation rate (mm/hr) 7
Urea (mmol/L) 3.8
Creatinine (µmol/L) 70
Glucose fasting (mmol/L) 5.49
Bilirubin (mmol/L) 16.3
Alkaline phosphatase (U/L) 249
Gamma glutamyl transferase (U/L) 28
Alanine aminotransferase 46
Albumin (g/L) 39.1
Sodium (mmol/L) 140
Potassium (mmol/L) 3.07
Chloride (mmol/L) 107
Calcium (mmol/L) 2.17
Phosphate (mmol/L) 0.9
Uric acid (µmol/L) 208
Thyroid stimulating hormone (U/L) 0.41
International normalised ratio 1.0
Urinalysis and microscopy Normal
Electrocardiogram Normal sinus rhythm
Initial screening investigations are shown in Table 1.  A chest
radiograph showed an inhomogenous opacity with ill-defined
outlines at the left apex.  There was no hilar lymphadenopathy.
Abdominal ultrasonography showed an enlarged liver without
any focal lesions; the gallbladder, spleen and kidneys were
reported as normal and no free fluid was detected in the
abdomen.  On computed tomography of the thorax a mass was
identified in the posterior segment of the upper lobe subpleurally
with extension to the chest wall and destruction of the adjacent
rib (Figure 1).  Significant fibrotic changes were noted in the
same lobe. There was no mediastinal lymphadenopathy, pleural,
or pericardial effusion.
The patient was admitted for fibreoptic bronchoscopy.
Widespread inflammatory changes in keeping with early chronic
obstructive pulmonary disease were note.  No intrabronchial
lesions were identified.  Brush biopsies from the left upper lobe
bronchus were submitted and reported negative for malignant
cells.  Bronchial lavage samples were sent for cytology, Ziehl-
Neelsen staining and culture.
Haemophilus influenzae was identified and treated however
other tests were normal.  During his admission, the patient
complained of further abdominal distension.  Paracentesis at
the right iliac fossa did not yield any fluid.  At this point the
patient was discharged with a follow-up appointment for
bronchoscopy sample results.
Nine days after discharge, he presented to the Accident and
Emergency department with severe abdominal pain and
worsening abdominal distension.  He had been taking diclofenac
for left shoulder pain over the previous few days.  Physical
examination on admission showed a distended abdomen
suggestive of ascites and signs of peritonitis.  A chest radiograph
disclosed air under the diaphragm. Pre-op investigations taken
soon after arrival at A&E are given in Table 2.  An urgent
laparotomy was performed.  At surgery, there was perforation
of the sigmoid colon together with a pelvic abscess.  No gross
abnormalities were detected on direct visualisation of the liver,
stomach, duodenum, spleen, gallbladder and kidneys.  Partial
sigmoid colectomy was performed with fashioning of an end
colostomy in the left iliac fossa together with routine
appendicectomy.  The resected specimens were submitted for
histology and were reported as “periappendicitis, sigmoid colon
segment with multiple diverticuli and some serosal
inflammation”.  Streptococcus constellatus, Escherichia coli,
and Bacteroides fragilis were cultured from peritoneal fluid
samples.
The post-operative period, initially in the ICU and
subsequently in a surgical ward, was marked by severe refractory
hypokalaemia requiring massive doses of potassium
replacement.  Figure 2 shows his daily serum potassium level
and the amount of potassium administered in various forms
over the days he remained in hospital.  Despite the large doses
given, serum potassium was rarely within the physiological
range (dotted lines).  Hypokalaemia was initially attributed to
gastrointestinal losses following bowel resection, however the
unusual severity and persistence prompted further
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investigations (Table 3).  These pointed to a diagnosis of
hypercortisolism secondary to increased ACTH production.
During this period, the patient developed a hospital-
acquired pneumonia which proved difficult to treat and he was
given successively meropenem, piperacillin, clarithromycin and
levofloxacin.  Sputum studies were negative for acid-fast bacilli
but Alcaligens xylosidans was subsequently isolated.  Apart
from potassium supplementation and antibiotics, the patient
was being treated with nebulised bronchodilators, diuretics
including spironolactone due to his lower limb oedema and
insulin as he eventually developed hyperglycaemia.  Once it was
established that the patient had hypercortisolism, a cortisol
biosynthesis inhibitor was added to his treatment regime.
Metyrapone 50mg TDS lowered serum cortisol to 444nmol/L
after 5 days.  When patient’s clinical condition became more
stable, a computed tomography-guided biopsy of the left lung
lesion was performed.  Histological examination of the biopsy
specimen confirmed a diagnosis of small-cell carcinoma (Figure
3).  Further work-up included computed tomography of the
brain which was normal, and a bone scan which showed
increased tracer uptake suggestive of vertebral collapse in T4,
T7 and T9 to T11 vertebrae.  It was suggested that these were
features of a diffuse bone disease rather than metastases.
Three and a half months after his initial presentation, the
patient suddenly developed severe dyspnoea and a clinical
diagnosis of tension pneumothorax was made.  An urgent
thoracocentesis was performed with complete lung re-inflation.
Despite this, the overall clinical condition rapidly deteriorated
and the patient died soon after.
Discussion
The association between non-pituitary tumours and
Cushing’s syndrome was first reported by Brown in 1928.1
Small-cell lung cancer is characterised by numerous
paraneoplastic syndromes and ectopic secretion of corticotropin
( ACTH ) is one of the rare complications, being found in less
than 5% of patients with this disease.2-4
ACTH and other pituitary peptides are synthesised from a
common high molecular weight precursor pro-
opiomelanocortin ( POMC ), which is cleaved to pro-ACTH and
subsequently the active ACTH 1-39.  Although POMC
Figure 2: K+ levels and  K+ Supplementation during hospital stay
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Figure 3: CT-guided specimen histology showing the typical
hyperchromatic cells with scanty cytoplasm found in small cell
lung carcinoma
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Table 4: Types of tumour causing ectopic ACTH
Small cell lung cancer
Bronchial carcinoid
Other carcinoid tumours ( thymus, small intestine )
Pancreatic islet cell tumour
Phaeochromocytoma
Medullary carcinoma of thyroid
Carcinomas ( breast, GI tract, ovarian, cervical, prostate )
Table 5: Frequency of clinical features of ectopic ACTH
syndrome associated with small-cell lung cancer3
Symptom %
Peripheral oedema 83
Proximal myopathy 61
Moon face 52
Truncal obesity 35
Hyperpigmentation 22
Psychosis 22
Hypertension 22
Ecchymoses 17
Hirsutism 4
Striae 4
Table 6: Steroid-synthesis blocking therapy in
ectopic ACTH syndrome
Drug Mechanism of action
Metyrapone Inhibition of 11beta-hydroxylase
Ketoconazole Inhibition of cortisol synthesis
Aminoglutethimide Inhibition of cholesterol
conversion to pregnenolone
Octreotide Inhibition of ACTH secretion
Etomidate Adrenolytic
Mitotane Adrenolytic 
transcription occurs predominantly in the pituitary, low level
expression has been detected in a variety of other tissues.5  Many
different types of tumours have been found to contain
immunoreactive ACTH and other POMC-derived peptides.5,6
However, the actual incidence of secretion of excess ACTH is
much less common – probably related to the absence of an
essential signal sequence for translocation in peripheral cell
mRNA.7  Table 4 lists the types of tumour associated with ectopic
ACTH secretion.  It is postulated that in these types of
malignancy, changes in gene promoter regions or proliferation
of cells producing the longer POMC mRNA enable secretion of
active ACTH.
Refractory hypokalaemia was a prominent feature of the
case reported.  The clinical features of ectopic Cushing’s
syndrome show a number of differences from the classical
symptom complex and often metabolic abnormalities may be
the only manifestations.  Hypokalaemia, usually associated with
metabolic alkalosis, is present in more than 90% of patients
with ectopic ACTH, compared to an incidence of 10% in
Cushing’s syndrome due to other aetiologies.8  The characteristic
hypo-kalaemia is caused by a combination of excessive cortisol
levels overwhelming 11 beta-hydroxysteroid dehydrogenase
(the principal enzyme metabolising glucocorticoids) which
shows reduced activity under the influence of ACTH and the
mineralocorticoid actions of corticosterone and 11-deoxy-
corticosterone. 8-10
In addition, proximal muscle weakness, weight loss,
oedema, impaired glucose tolerance, mental disorders and
striking hyperpigmentation are often prominent clinical
features.  The typical changes in body morphology are usually
absent probably due to the rapid onset of the disease and the
fast rate of progression.  Table 5 shows the frequency of
symptoms in ectopic ACTH syndrome associated with small-
cell lung cancer.
The occurrence of small-cell lung cancer with ectopic ACTH
is associated with a high incidence of infective complications
( up to 40 – 50% of patients ).3,11   Cases of Pneumocystis carinii
pneumonia, invasive aspergillosis, cryptococcosis, nocardiosis,
superficial fungal infections and oral candidiasis have been
reported highlighting an increased susceptibility to
opportunistic infections unrelated to neutropenia or
chemotherapy.12-16  In our patient, it is likely that at presentation
he was already suffering from diverticulitis with spasm of the
bowel wall leading to incomplete obstruction and abdominal
distension; this was repeatedly misdiagnosed by different
physicians as ascites.  Hypercortisolism masked many of the
signs and symptoms of inflammation and the infective process
progressed to a pericolic abscess and eventual perforation.  His
post-operative period was also marked by numerous chest
infections.  The isolation of the low-grade nosocomial pathogen
Alcaligens xylosidans is unusual in immuno-competent
individuals.
High dose dexamethasone suppression test is used to
differentiate between ectopic and pituitary-dependent Cushing’s
syndrome, where 89% of patients with ectopic ACTH secretion
fail to suppress.8,10,17,18  The altered sensitivity to dexamethasone
inhibition may be due to defective action of the glucocorticoid
receptor or presence of a glucocorticoid inhibitor within the
cells.19,20
Treatment consists of cytotoxic chemotherapy directed
against the underlying small-cell lung cancer.  However it is
usually recommended to start steroid-synthesis blockade before
embarking on chemotherapy in an attempt to control
hypercortisolism.  A number of medications (Table 6) are
available but there are various problems associated with their
use.21-24   Ketoconazole is probably the best alternative as it is
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Figure 4:  Variation of Ca2+, PO4- and ALP through hospital stay
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the least toxic.  An alternative is bilateral surgical adrenalectomy,
however this is usually reserved for slow-growing tumours or
instances when the site of the primary tumour is
undetermined.26
Another atypical feature in the case presented was the bone
disease.  The patient had been complaining of low back pain
throughout his second admission.  The bone scan did not
disclose malignancies but rather thoracic vertebral collapse in
keeping with diffuse bone disease.  The early demise of the
patient precluded further assessment to determine the precise
nature of the lesions.  One of the possibilities in a
hypercortisolaemic state is obviously osteoporosis.  The
incidence of osteoporosis in small-cell lung cancer does not seem
to have been documented in the literature. However anecdotal
evidence suggests that incidence is very low probably due to
the short natural history of the disease.  The other alternative is
oncogenic osteomalacia – a paraneoplastic syndrome usually
associated with benign head and neck tumours but increasingly
reported in cases of malignant carcinomas especially small-cell
tumours.26,27  Oncogenic osteomalacia is characterised by
decreased bone mineralisation secondary to hypo-
phosphataemia in a way similar to X-linked vitamin D resistant
rickets.  Secretion of phosphatonin,
a paraneoplastic factor is thought to inhibit tubular
reabsorption of phosphate and conversion of 25- to
1,25-dihydroxyvitamin D.28  Fibroblast growth factor 23 is the
strongest candidate as the postulated ‘phospatonin’.29  The
disease is characterised by bone pains, fractures and muscle
weakness.  Serum phosphate is very low while calcium and
parathyroid hormone level are usually within the normal range.
Alkaline phosphatase levels are elevated and 24-hour urinary
phosphate excretion is high.30  Figure 4 outlines the calcium,
phosphate and alkaline phosphatase assays throughout the
patient’s hospital stay.
Ectopic ACTH secretion is associated with a poor prognosis
in small-cell lung cancer, due to a combination of factors –
tumour burden is usually larger, there is less response to
cytotoxic chemotherapy and infectious complications.  The
median survival reported in the literature from time of diagnosis
is approximately 6 months.4,11,13
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